Latest News
UK private equity house Maven Capital Partners has invested GBP1 million in ebb3, with the potential for an additional GBP0.5 million of follow-on funding.
ebb3 is a technology services business operating in a niche part of the high performance computing market. It delivers data intensive 3D graphical applications to customers on any device using High Performance Virtual Computers (HPVCs) and its solutions negate the need for businesses to maintain and run traditional fixed location computer workstations across their organisations.
ebb3’s technology is able to drive heavyweight applications for the likes of computer assisted design (CAD) or computer generated
ViraTherapeutics, a biopharmaceutical company developing virus-based immunotherapeutics, which is backed by Boehringer Ingelheim Venture Fund (BIVF), has appointed Dr Heinz Schwer as CEO.
He takes over the position from interim CEO and co-founder Professor Dr Dorothee von Laer, who will remain a scientific adviser.
Schwer is a biotech executive with strong experience in strategic leadership, business development, M&A and drug development.
Prior to joining ViraTherapeutics, Schwer served as CEO of Lanthio Pharma at the time the company was acquired by MorphoSys. He was previously founder and CEO of Sloning BioTechnology, which was sold to MorphoSys, where he
AB Tasty has secured a USD17 million Series B investment from Korelya Capital and Partech Ventures, with participation from previous investors Xange Private Equity and Omnes Capital.
AB Tasty will use this round of funding to extend its leadership position in conversion rate optimization and accelerate its commercial development in the US, where the company will focus on expanding its current portfolio of clients such as Sephora, Mercedez-Benz, Groupon and Pizza Hut.
“We have had triple digit growth rates in Europe for the past consecutive six years and have built a substantial portfolio of customers,” says Alix de
Peapack-Gladstone Financial Corporation, parent company of Peapack-Gladstone Bank, is to acquire New Jersey-based Murphy Capital Management (MCM).
After up front transaction costs, the purchase will be immediately accretive to earnings.
Doug Kennedy, president and chief executive officer of Peapack-Gladstone Bank, says: “We have found what we feel is the perfect match with MCM and are thrilled this leader in the wealth management space, that shares our geography, will partner with us by joining our private wealth management team.”
Founded in 1983 by John J. Murphy, MCM adheres to a sophisticated and objective method to creating wealth and
Private equity firm Irving Place Capital (IPC) has agreed to sell thermal technology company Chromalox to Spirax-Sarco Engineering, a UK-based company specialising in the control and efficient use of steam and other industrial fluids, for USD415 million in cash.
Completion of the transaction is subject to customary closing conditions.
Chromalox is a technology company that delivers temperature management and process heating solutions for customers in a diverse range of industrial markets.
Chromalox was founded in 1917 and is headquartered in Pittsburgh, PA. IPC acquired Chromalox in December 2012.
“It has been a pleasure to work with
Free Form Factory, a designer and builder of electric watercraft, has closed its latest seed funding round, raising USD500,000 from a group of investors.
It is preparing for a Series A funding round of USD3.5 million.
“With the announcement of our electric-powered Gratis X1, we are moving quickly to deliver to the market a watercraft that has disrupted the traditional thinking within the personal watercraft space.” says founder and CEO of Free Form Factory Jordan Darling.
“Our initial investors have allowed Free Form Factory to design, develop, and launch an exhilarating electric personal watercraft that will soon
Bluebee, a provider of high-performance genomics analysis and storage solutions, and MediSapiens, a biomedical big data curation, management and interpretation company, have formed a partnership to provide customers with analytical solutions for next generation sequencing data.
Sequencing technology is maturing and being optimised for performance, while becoming increasingly affordable. This has opened an era of reliable and foreseeable quality data growth, which demands high computational resources and data storage capabilities to be combined with best in class data interpretation tools.
MediSapiens’ Explorer Platform is now integrated with the Bluebee platform, offering researchers and clinicians the ability to efficiently
The recent launch of Blackstone Infrastructure I demonstrates the long-term trend towards capital concentration in the unlisted infrastructure market, says Preqin, with investors looking to commit more capital to fewer fund managers.
This means that while fundraising as a whole is at record levels, the majority of it is secured by a small coterie of firms.
Funds closing with USD1.5 billion or more in investor commitments have accounted for three-quarters of the total capital raised in 2016 and 2017 so far – mega funds alone account for half of 2017 YTD fundraising.
Furthermore, the record for the
Alternative capital is becoming more mainstream, at least in the UK mid-market, according to a panel of capital providers assembled by mid-market M&A association, ACG UK.
The ‘Trends in Alternative Capital’ panel debate, the latest in ACG UK’s ‘Trends in…’ series, revealed broad agreement among the panellists, who represented the banking, private debt, asset based lending, private equity and corporate finance communities, that the funding environment for mid-market and SME businesses has evolved rapidly over the last five years.
This is resulting in closer collaboration between the different capital providers and more flexible and tailored financial solutions being
Eastspring Investments, the USD146 billion Asian investment management arm of Prudential, is to invest an undisclosed amount in Watsun Infrabuild Private Limited, a wholly owned subsidiary of Continuum Wind Energy.
The transaction is likely to close by June 2017.
Watsun is constructing a 150 MW wind power project in Tamil Nadu, India comprising 75 advanced Vestas V100 2.0 MW wind turbines to be commissioned in two phases of 54 MW and 96 MW each.
The capital invested by Eastspring will be used to fund the construction activities of phase II of the project.
Vestas has been
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
